LYEL
Lyell Immunopharma Inc
NASDAQ: LYEL · HEALTHCARE · BIOTECHNOLOGY
$19.73
-4.22% today
Updated 2026-04-30
Market cap
$527.78M
P/E ratio
—
P/S ratio
14,660.60x
EPS (TTM)
$-16.06
Dividend yield
—
52W range
$8 – $45
Volume
0.1M
Lyell Immunopharma Inc (LYEL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-151.2%
Last 4 quarters
Revenue YoY growth
-45.5%
Most recent quarter
EPS YoY growth
-1625.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.7%
2026-03-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-7.68 | -244.1% | $24.78 | $21.13 | -14.7% |
| 2025-11-12 | $-2.13 | -1180.0% | $17.25 | $17.41 | +0.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.23 | $-7.68 | -244.1% | $6000.00 | -45.5% |
| 2025-09-30 | $-0.17 | $-2.13 | -1180.0% | $15000.00 | -55.9% |
| 2025-06-30 | $-0.16 | $-2.89 | -1669.7% | $8000.00 | -38.5% |
| 2025-03-31 | $-0.17 | $-0.18 | -4.9% | $7000.00 | +133.3% |
| 2024-12-31 | $-0.19 | $-0.45 | -131.2% | $11000.00 | -15.4% |
| 2024-09-30 | $-0.20 | $-0.19 | +5.0% | $34000.00 | +36.0% |
| 2024-06-30 | $-0.18 | $-0.18 | -0.3% | $13000.00 | -51.9% |
| 2024-03-31 | $-0.24 | $-0.24 | +0.3% | $3000.00 | -95.4% |
| 2023-12-31 | $-0.23 | $-0.20 | +13.0% | $13000.00 | — |
| 2023-09-30 | $-0.25 | $-0.17 | +32.0% | $25000.00 | — |
| 2023-06-30 | $-0.27 | $-0.18 | +33.3% | $27000.00 | — |
| 2023-03-31 | $-0.28 | $-0.23 | +17.9% | $65000.00 | — |
Frequently asked questions
Has Lyell Immunopharma Inc beaten earnings estimates?
Lyell Immunopharma Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -151.2% over the last 4 quarters.
How does LYEL stock react to earnings?
LYEL stock has moved an average of -6.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Lyell Immunopharma Inc's revenue growth rate?
Lyell Immunopharma Inc reported year-over-year revenue growth of -45.5% in its most recent quarter, with EPS growing -1625.8% year-over-year.